UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Therapeutic innovation in drug repurposing: Challenges and opportunities

Recino, Asha; Rayner, Melissa LD; Rohn, Jennifer L; Pasqua, Oscar Della; UCL Repurposing TIN, Committee; (2025) Therapeutic innovation in drug repurposing: Challenges and opportunities. Drug Discovery Today , Article 104390. 10.1016/j.drudis.2025.104390. (In press). Green open access

[thumbnail of Della Pasqua_Therapeutic innovation in drug repurposing_Pre-proof.pdf]
Preview
Text
Della Pasqua_Therapeutic innovation in drug repurposing_Pre-proof.pdf

Download (1MB) | Preview

Abstract

Drug repurposing leverages existing drugs for new therapeutic uses, offering significant opportunities but facing challenges such as financial and regulatory barriers and the need for robust evidence for an efficient clinical development plan. This paper examines the critical steps in drug repurposing and their role in improving study success rates. It also highlights the support infrastructure provided by the University College London (UCL) Repurposing Therapeutic Innovation Network (TIN), as a partnership model to address these challenges through diverse expertise, enterprise insight, and tailored guidance. By fostering collaborations and offering structured support, the Repurposing TIN aims to accelerate repurposing efforts and deliver patient benefits. We invite potential collaborators to join us in advancing drug repurposing through innovative and strategic approaches.

Type: Article
Title: Therapeutic innovation in drug repurposing: Challenges and opportunities
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.drudis.2025.104390
Publisher version: https://doi.org/10.1016/j.drudis.2025.104390
Language: English
Additional information: © 2025 The Authors. Published by Elsevier Ltd. under a Creative Commons license (http://creativecommons.org/licenses/by/4.0/).
Keywords: drug repurposing, translational pharmacology, proof of concept, clinical development plan, regulatory approval, therapeutic innovation, private-public partnerships, attrition
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Pharmacology
URI: https://discovery.ucl.ac.uk/id/eprint/10209401
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item